TQAIX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TQAIX Analyst Rating

Moderate Buy

285 Buy

35 Hold

1 Sell

Based on the consensus analyst ratings on 321 stocks held in TQAIX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TQAIX Analyst Price Target

Average Price Target

$49.39

Based on 321 Wall Street analysts offering 12 month price targets to T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class holdings in the last 3 months. The average price target is $49.39 with a high forecast of $60.98 and a low forecast of $41.42. The average price target represents a 23.11% change from the last price of $40.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","50":"$50","61":"$61","44.5":"$44.5","55.5":"$55.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60.98,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.391,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$49.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.419,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$41.42</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,44.5,50,55.5,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.09,43.543076923076924,44.996153846153845,46.44923076923077,47.902307692307694,49.355384615384615,50.808461538461536,52.261538461538464,53.714615384615385,55.167692307692306,56.62076923076923,58.07384615384615,59.52692307692307,{"y":60.98,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.09,42.65161538461539,43.21323076923077,43.774846153846156,44.33646153846154,44.89807692307692,45.45969230769231,46.021307692307694,46.58292307692308,47.14453846153846,47.706153846153846,48.26776923076923,48.82938461538461,{"y":49.391,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.09,42.038384615384615,41.986769230769234,41.935153846153845,41.883538461538464,41.831923076923076,41.780307692307694,41.728692307692306,41.677076923076925,41.625461538461536,41.573846153846155,41.52223076923077,41.470615384615385,{"y":41.419,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":44.01,"date":1717372800000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.28,"date":1719792000000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.04,"date":1722470400000,"info":"<div>Price: <b>$46<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.02,"date":1725321600000,"info":"<div>Price: <b>$46<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":47.57,"date":1727740800000,"info":"<div>Price: <b>$48<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":47.4,"date":1730419200000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":51.17,"date":1733097600000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":43.56,"date":1735776000000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.89,"date":1738540800000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":41.59,"date":1740960000000,"info":"<div>Price: <b>$42<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.12,"date":1743465600000,"info":"<div>Price: <b>$40<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.33,"date":1746057600000,"info":"<div>Price: <b>$40<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":42.09,"date":1748822400000,"info":"<div>Price: <b>$42<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$60.98

Average Price Target$49.39

Lowest Price Target$41.42

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TQAIX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IOVA

Iovance Biotherapeutics

―

7 Buy

5 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DYN

Dyne Therapeutics, Inc.

―

13 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PRTA

Prothena Corporation

―

4 Buy

4 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RCKT

Rocket Pharma

―

10 Buy

7 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GLUE

Monte Rosa Therapeutics, Inc.

―

3 Buy

0 Hold

0 Sell

Strong Buy

―

TQAIX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Mp Materials Corp

―

7 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

KRMN

Karman Holdings Inc.

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LEU

Centrus Energy

―

6 Buy

3 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FLR

Fluor Corporation

―

5 Buy

3 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RKLB

Rocket Lab Usa, Inc.

―

9 Buy

3 Hold

0 Sell

Strong Buy

―

TQAIX Mutual Fund FAQ

What is TQAIX’s average 12-month price target, according to analysts?

Based on analyst ratings, T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class’s 12-month average price target is 49.39.

What is TQAIX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for TQAIX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TQAIX a Buy, Sell or Hold?

T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class has a consensus rating of Moderate Buy which is based on 285 buy ratings, 35 hold ratings and 1 sell ratings.

What is T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class’s price target?

The average price target for T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class is 49.39. This is based on 321 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.98 ,the lowest forecast is $41.42. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class?

T. Rowe Price QM U.S. Small-Cap Growth Equity Fund - I Class’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 321 Wall Streets Analysts.

How can I buy shares of TQAIX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing